Navigation Links
Sepramesh Biosurgical Composite

ProductsSepramesh Biosurgical Composite
Company Genzyme Biosurgery
Item Sepramesh Biosurgical Composite
Features 
  • Designed for the repair of abdominal hernias
  • It consists of a PPM mesh that has two distinct sides: one is coated with a layer of sodium hyaluronate and carboxymethylcellulose and the other side is uncoated
  • The composite design encourages complete tissue incorporation (repair strength) on the hernial defect while minimizing tissue attachment to the mesh
  • Description Sepramesh Biosurgical Composite is designed for the repair of abdominal hernias. It consists of a PPM mesh that has two distinct sides. One side of the mesh is coated with a layer of sodium hyaluronate and carboxymethylcellulose (similar to Genzyme Biosurgery's Seprafilm® Adhesion Barrier). This coated side is bioresorbable, providing a temporary physical barrier that separates the underlying tissue and organ surfaces from the mesh. The other side of the mesh is uncoated, allowing for complete tissue ingrowth similar to bare PPM mesh. Shortly after placement of Sepramesh, the coated side of the mesh becomes a hydrated gel that is slowly resorbed into the body within one week. The bioresorbable barrier separates the mesh from underlying organs while a protective cell layer forms over the mesh. The composite design encourages complete tissue incorporation (repair strength) on the hernial defect while minimizing tissue attachment to the mesh.
    Info Genzyme Biosurgery
    Customer Service: (888) 379-6847
    Web site: http://www.genzymebiosurgery.com/

    Related medicine products :

    1. Composite Tabletop For An Urological Imaging System
    For the quantitative in vitro determination of Ammonia in plasma...
    For the quantitative in vitro determination of Sodium in serum and plasma....
    Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma....
    Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
    Medicine Products:
    (Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
    (Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
    (Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
    Breaking Medicine News(10 mins):
    (Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
    (Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
    (Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
    Breaking Medicine Technology: